Suresh M. Kumar, Ph.D.

Suresh M. Kumar, Ph.D.
Staff Scientist

Dr. Suresh Kumar has been working in the field of molecular biology and cell biology of cancer and stem cell biology. Dr. Kumar has made significant contribution in the field of cancer research well as regenerative medicine. His primary research interest and expertise focus on the molecular mechanism behind tumor micro environment, drug resistance and cancer metastasis.

 

Areas of Expertise
1) cancer cell signaling pathways 2) cancer stem cells (CSCs) 3) hypoxia and tumor microenvironment (TME) 4) epidermal stem cells 5) melanoma and thyroid cancer 6) circulating tumor cells (CTCs)

Contact Info

Suresh M. Kumar, Ph.D.
Center for Cancer Research
National Cancer Institute
Building 10, Room No:3W-5840
Bethesda, MD 20892
Ph: 301- 451-1041
suresh.kumar@nih.gov

Dr. Suresh Kumar's primary research interest and expertise focus on the molecular mechanism behind tumor microenvironment, drug resistance and cancer metastasis and identification of circulating tumor cells using nanotechnology and biology of exosome and immunotherapy.

Scientific Focus Areas:
Cancer Biology, Cell Biology, Molecular Biology and Biochemistry, Stem Cell Biology

Selected Key Publications

  1. Kumar SM, Dai J, Li S, Yang R, Yu H, Nathanson KL, Liu S, Zhou H, Guo J, Xu X.
    Oncogene. 33 (7): 832-41, 2014. [ Journal Article ]
  2. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, Guerra M, Guo W, Xu X.
    Oncogene. 31(47): 4898-911, 2012. [ Journal Article ]
  3. Kumar SM, Zhang G, Bastian BC, Arcasoy MO, Karande P, Pushparajan A, Acs G, Xu X.
    Oncogene. 31(13): 1649-60, 2012. [ Journal Article ]
  4. Yang R, Zheng Y, Burrows M, Liu S, Wei Z, Nace A, Guo W, Kumar S, Cotsarelis G, Xu X.
    Nature Communication. 5: 3071, 2014. [ Journal Article ]
  5. Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, Guo W, Xu X.
    Journal of Pathology. 226(1): 61-72, 2012. [ Journal Article ]

Dr. Kumar completed his M.S. and Ph.D. in biotechnology from Cochin University of Science and Technology, India. He completed his postdoctoral training in the molecular biology of breast cancer at Indiana University (Indianapolis, IN) and at Tufts University (Boston, MA). Dr. Kumar worked as a research faculty member at the Department of Pathology, University of Pennsylvania (Philadelphia, PA) and at the Milton Hershey Cancer Institute, Penn State University (Hershey, PA) and as an academic faculty member at Pennsylvania State University (Harrisburg, PA) before joining the Center for Cancer Research, NCI, NIH.